ES2072163T3 - Compuestos de inclusion de acido 5,10-metilenotetrahidrofolico y ciclodextrina. - Google Patents
Compuestos de inclusion de acido 5,10-metilenotetrahidrofolico y ciclodextrina.Info
- Publication number
- ES2072163T3 ES2072163T3 ES93110567T ES93110567T ES2072163T3 ES 2072163 T3 ES2072163 T3 ES 2072163T3 ES 93110567 T ES93110567 T ES 93110567T ES 93110567 T ES93110567 T ES 93110567T ES 2072163 T3 ES2072163 T3 ES 2072163T3
- Authority
- ES
- Spain
- Prior art keywords
- acid
- cyclodextrin
- tethydropholic
- methylene
- inclusion compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Ink Jet (AREA)
- Ink Jet Recording Methods And Recording Media Thereof (AREA)
Abstract
LA INVENCION SE REFIERE A NUEVOS COMPUESTOS DE INCLUSION DE CICLODEXTRINA DEL ACIDO 5,10-METILENOTETRAHIDROFOLICO. LA SORPRENDENTE BUENA ESTABILIDAD DEL COMPUESTO POSIBILITA POR PRIMERA VEZ SU APLICACION FARMACEUTICA. LA INVENCION SE REFIERE ADEMAS A UN PROCEDIMIENTO PARA PRODUCIR LAS SUBSTANCIAS MENCIONADAS Y SU APLICACION PARA LA PRODUCCION DE MEDICAMENTOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH2192/92A CH684644A5 (de) | 1992-07-13 | 1992-07-13 | 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2072163T3 true ES2072163T3 (es) | 1995-07-01 |
Family
ID=4228046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93110567T Expired - Lifetime ES2072163T3 (es) | 1992-07-13 | 1993-07-02 | Compuestos de inclusion de acido 5,10-metilenotetrahidrofolico y ciclodextrina. |
Country Status (18)
Country | Link |
---|---|
US (1) | US5455236A (es) |
EP (1) | EP0579996B1 (es) |
JP (1) | JP2667354B2 (es) |
KR (1) | KR100217788B1 (es) |
CN (1) | CN1032901C (es) |
AT (1) | ATE121949T1 (es) |
AU (1) | AU661591B2 (es) |
CA (1) | CA2100126C (es) |
CH (1) | CH684644A5 (es) |
DE (1) | DE59300176D1 (es) |
DK (1) | DK0579996T3 (es) |
ES (1) | ES2072163T3 (es) |
FI (1) | FI933151A (es) |
HU (2) | HU212665B (es) |
NO (1) | NO303715B1 (es) |
RU (1) | RU2135519C1 (es) |
TW (1) | TW379142B (es) |
ZA (1) | ZA934907B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5906981A (en) * | 1996-06-04 | 1999-05-25 | Troy Corporation | Halopropargyl inclusion complexes |
CH693255A5 (de) * | 1997-06-13 | 2003-05-15 | Eprova Ag | Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels. |
CN1095472C (zh) * | 2000-04-17 | 2002-12-04 | 上海复康医药科技发展有限公司 | 叶酸-多聚糖复合物,其制备方法和以该复合物为活性成分的药物组合物 |
DE602005026352D1 (de) * | 2004-09-15 | 2011-03-31 | Nipro Corp | Wässrige, stabile (6S)-Folinsäurelösung zur Injektion |
AU2008222592B2 (en) * | 2007-03-02 | 2013-09-26 | Detsamma Investments Pty Ltd | Compositions and methods for delivery of anti-cancer agents |
CN101235102B (zh) * | 2008-02-18 | 2010-11-03 | 南昌航空大学 | 一种叶酸偶联羟丙基壳聚糖纳米微粒的制备方法 |
CN102000345A (zh) * | 2010-11-16 | 2011-04-06 | 广西大学 | 包合态的叶酸/β-环糊精组合物及其制备方法 |
CN102258788B (zh) * | 2011-06-13 | 2012-11-07 | 南开大学 | 一种靶向传递阿霉素抗癌药的组装体及其制备方法 |
EP2837631A1 (en) | 2013-08-14 | 2015-02-18 | Merck & Cie | New stable salt of 5,10-methylene-(6R)-tetrahydrofolic acid |
RU2537246C1 (ru) * | 2013-10-17 | 2014-12-27 | Федеральное государственное бюджетное учреждение "Научный центр клинической и эскпериментальной медицины" Сибирского отделения Российской академии медицинских наук ФГБУ "НЦКЭМ" СО РАМН | Способ получения биотинилированного производного окисленного декстрана |
EP2878600B1 (en) | 2013-12-02 | 2018-06-27 | Cerbios-Pharma S.A. | Stable complexes of an alkaline earth metal salt of N5-methyl-tetrahydrofolic acid and a polyol |
KR20200041354A (ko) | 2017-08-16 | 2020-04-21 | 메르크 파텐트 게엠베하 | 5,10-메틸렌-(6r)-테트라하이드로폴산 및 디카르복시산을 포함하는 안정한 동결건조물 |
CN112089848A (zh) * | 2020-10-27 | 2020-12-18 | 浙江诺得药业有限公司 | 叶酸的环糊精包合物及其制备方法 |
WO2023237482A1 (en) | 2022-06-08 | 2023-12-14 | Merck Patent Gmbh | Concentrated solutions comprising sodium 5,10-methylene-(6r)- tetrahydrofolate |
WO2023237480A1 (en) | 2022-06-08 | 2023-12-14 | Merck Patent Gmbh | Stable pharmaceutical compositions comprising 5,10-methylene-(6r)-tetrahydrofolic acid and nacl |
WO2023237485A1 (en) | 2022-06-08 | 2023-12-14 | Merck Patent Gmbh | Stable lyophilisates comprising 5,10-methylene-(6r)-tetrahydrofolic acid |
WO2023237483A1 (en) | 2022-06-08 | 2023-12-14 | Merck Patent Gmbh | Concentrated solutions comprising 5,10-methylene-(6r)-tetrahydrofolic acid |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0031237B1 (en) * | 1979-12-19 | 1984-10-17 | National Research Development Corporation | Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents |
US4350659A (en) * | 1981-07-30 | 1982-09-21 | Corning Glass Works | Stabilization of sensitive biologically active intermediate metabolites such as folic acid derivatives |
JPS602775B2 (ja) | 1981-08-28 | 1985-01-23 | 富士通株式会社 | モニタ機能付大規模集積回路及びその製造方法 |
JPS59175432A (ja) * | 1983-03-25 | 1984-10-04 | Yatoron:Kk | ジヒドロ葉酸溶液の安定化方法 |
JPS62281855A (ja) * | 1986-05-29 | 1987-12-07 | Daikin Ind Ltd | ビタミン,ビタミン誘導体,またはホルモンを含有する包接化合物 |
GB8621268D0 (en) * | 1986-09-03 | 1986-10-08 | Univ Strathclyde | Separation of substances |
US4857530A (en) * | 1987-11-03 | 1989-08-15 | Warner-Lambert Company | Substituted quinazolinones as anticancer agents |
NL8901432A (nl) * | 1989-06-06 | 1991-01-02 | Pharmachemie Bv | Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan. |
CA2021042A1 (en) | 1989-07-21 | 1991-01-22 | Fabrizio Marazza | Salts of n ,n -methylene-5,6,7,8-tetrahydrofolic acid |
ATE126438T1 (de) | 1989-08-21 | 1995-09-15 | American Cyanamid Co | Stabile injizierbare pharmazeutische formulation mit folinsäure und leukovorinsalze und verfahren. |
IT1237509B (it) | 1989-10-31 | 1993-06-08 | Magis Farmaceutici | Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche |
CH680731A5 (es) * | 1990-04-12 | 1992-10-30 | Sapec Fine Chemicals | |
AU7953291A (en) | 1990-05-11 | 1991-12-10 | Goran Carlsson | 5,10-methylene-tetrahydrofolate as a modulator of a chemotherapeutic agent |
US5153309A (en) * | 1990-07-27 | 1992-10-06 | The United States Of America As Represented By The Department Of Health And Human Services | Process of making tetrahydropteroylpoly-l-glutamic acid derivatives |
CH681303A5 (es) | 1991-01-16 | 1993-02-26 | Eprova Ag | |
AU657986B2 (en) * | 1991-06-14 | 1995-03-30 | Pharmacia & Upjohn Company | Imidazo(1,5-a)quinoxalines |
-
1992
- 1992-07-13 CH CH2192/92A patent/CH684644A5/de not_active IP Right Cessation
-
1993
- 1993-06-30 TW TW082105224A patent/TW379142B/zh not_active IP Right Cessation
- 1993-07-02 ES ES93110567T patent/ES2072163T3/es not_active Expired - Lifetime
- 1993-07-02 EP EP93110567A patent/EP0579996B1/de not_active Expired - Lifetime
- 1993-07-02 DK DK93110567.0T patent/DK0579996T3/da active
- 1993-07-02 AT AT93110567T patent/ATE121949T1/de not_active IP Right Cessation
- 1993-07-02 DE DE59300176T patent/DE59300176D1/de not_active Expired - Fee Related
- 1993-07-06 RU RU93047800A patent/RU2135519C1/ru active
- 1993-07-08 ZA ZA934907A patent/ZA934907B/xx unknown
- 1993-07-08 CA CA002100126A patent/CA2100126C/en not_active Expired - Fee Related
- 1993-07-09 AU AU41870/93A patent/AU661591B2/en not_active Ceased
- 1993-07-09 HU HU9301990A patent/HU212665B/hu not_active IP Right Cessation
- 1993-07-09 FI FI933151A patent/FI933151A/fi unknown
- 1993-07-09 NO NO932517A patent/NO303715B1/no not_active IP Right Cessation
- 1993-07-10 KR KR1019930012965A patent/KR100217788B1/ko not_active IP Right Cessation
- 1993-07-12 CN CN93108018A patent/CN1032901C/zh not_active Expired - Fee Related
- 1993-07-12 US US08/090,688 patent/US5455236A/en not_active Expired - Fee Related
- 1993-07-12 JP JP5171720A patent/JP2667354B2/ja not_active Expired - Lifetime
-
1995
- 1995-06-22 HU HU95P/P00333P patent/HU211484A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
HU9301990D0 (en) | 1993-09-28 |
TW379142B (en) | 2000-01-11 |
FI933151A0 (fi) | 1993-07-09 |
AU4187093A (en) | 1994-01-20 |
JP2667354B2 (ja) | 1997-10-27 |
RU2135519C1 (ru) | 1999-08-27 |
EP0579996A1 (de) | 1994-01-26 |
JPH0718084A (ja) | 1995-01-20 |
FI933151A (fi) | 1994-01-14 |
CN1081688A (zh) | 1994-02-09 |
CA2100126A1 (en) | 1994-01-14 |
ATE121949T1 (de) | 1995-05-15 |
NO932517L (no) | 1994-01-14 |
KR100217788B1 (ko) | 1999-09-01 |
AU661591B2 (en) | 1995-07-27 |
KR940002301A (ko) | 1994-02-17 |
CH684644A5 (de) | 1994-11-15 |
NO932517D0 (no) | 1993-07-09 |
HU212665B (en) | 1996-09-30 |
DE59300176D1 (de) | 1995-06-08 |
CA2100126C (en) | 1998-05-05 |
HU211484A9 (en) | 1995-11-28 |
CN1032901C (zh) | 1996-10-02 |
NO303715B1 (no) | 1998-08-24 |
US5455236A (en) | 1995-10-03 |
EP0579996B1 (de) | 1995-05-03 |
HUT65714A (en) | 1994-07-28 |
DK0579996T3 (da) | 1995-07-10 |
ZA934907B (en) | 1994-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2072163T3 (es) | Compuestos de inclusion de acido 5,10-metilenotetrahidrofolico y ciclodextrina. | |
DE3775882D1 (de) | Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen. | |
HU9401445D0 (en) | Nor-bile-acid derivatives, process for producing them and pharmaceutical compositions containing them | |
DE69027440D1 (de) | Bizyklische pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung | |
FI953139A0 (fi) | Atovakonia käsittäviä farmaseuttisia koostumuksia | |
AU1331588A (en) | Method for treatment of alcohol abuse | |
FI894899A0 (fi) | Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi | |
DE59008170D1 (de) | Verfahren zur Herstellung mikronisierter bioabbaubarer Partikel. | |
HUT48268A (en) | Process for producing pharmaceutical nukleozide and pharmaceutical compositions containing them | |
HUT50790A (en) | Process for producing new 3,5-dihydroxycarboxylic acids and derivatives thereof, as well as pharmaceutical compositions and intermediates comprising such compounds | |
HUT46664A (en) | Process for producing new dihydropyridineamide derivatives and pharmaceutical compositions comprising these compounds | |
RU93058177A (ru) | Производные пиридона, способ их получения, фармацевтическая композиция и промежуточные соединения синтеза | |
HUT58094A (en) | Process for producing 20,21-dinoreburnamenin derivatives and pharmaceutical compositions comprising such compounds, as well as their intermediates | |
FI900145A0 (fi) | Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi | |
PT87301A (pt) | Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them | |
DE3781879D1 (de) | Anthracyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
ATE118004T1 (de) | 4-amidino-chroman und 4-amidino-pyrano(3,2- c)pyridinderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
FI890678A (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi | |
HU904582D0 (en) | Process for producing amino-oligohydroxi derivatives and pharmaceutical preparatives containing those compounds | |
HUT54682A (en) | Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds | |
HUT49849A (en) | Process for producing ketenedithioacetal derivatives and pharmaceutical compositions comprising these compounds as active ingredient | |
PT88578A (pt) | Process for the manufacture of 2,6-methanopyrrolo-3-benzazocines of intermediates useful for their manufacture and of pharmaceutical compositions containing them | |
ATE45953T1 (de) | Anthracyclinderivate, deren verfahren zur herstellung und deren pharmazeutische zusammensetzung und deren benuetzung als arznei. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 579996 Country of ref document: ES |